• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    How To Earn $500 A Month From American Express Stock Ahead Of Q2 Earnings

    7/18/24 8:25:50 AM ET
    $AXP
    $EBS
    Finance: Consumer Services
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AXP alert in real time by email

    American Express Company (NYSE:AXP) will release its second-quarter financial results, before the opening bell on Friday, July 19.

    Analysts expect the New York-based company to report quarterly earnings at $3.25 per share, up from $2.89 per share in the year-ago period. American Express will post revenue of $16.59 billion, compared to $15.05 billion a year earlier, according to data from Benzinga Pro.

    On July 16, Compass Point analyst David Rochester initiated coverage on American Express with a Neutral rating and announced a price target of $260.

    With the recent buzz around American Express, some investors may be eyeing potential gains from the company's dividends, too. As of now, American Express offers an annual dividend yield of 1.12%. That’s a quarterly dividend amount of 70 cents per share ($2.80 a year).

    So, how can investors exploit its dividend yield to pocket a regular $500 monthly?

    To earn $500 per month or $6,000 annually from dividends alone, you would need an investment of approximately $535,664 or around 2,143 shares. For a more modest $100 per month or $1,200 per year, you would need $107,233 or around 429 shares.

    Read This: Alphabet, CrowdStrike And 2 Other Stocks Insiders Are Selling

    To calculate: Divide the desired annual income ($6,000 or $1,200) by the dividend ($2.80 in this case). So, $6,000 / $2.80 = 2,143 ($500 per month), and $1,200 / $2.80 = 429 shares ($100 per month).

    Note that dividend yield can change on a rolling basis, as the dividend payment and the stock price both fluctuate over time.

    How that works: The dividend yield is computed by dividing the annual dividend payment by the stock’s current price.

    For example, if a stock pays an annual dividend of $2 and is currently priced at $50, the dividend yield would be 4% ($2/$50). However, if the stock price increases to $60, the dividend yield drops to 3.33% ($2/$60). Conversely, if the stock price falls to $40, the dividend yield rises to 5% ($2/$40).

    Similarly, changes in the dividend payment can impact the yield. If a company increases its dividend, the yield will also increase, provided the stock price stays the same. Conversely, if the dividend payment decreases, so will the yield.

    AXP Price Action: Shares of American Express rose 0.1% to close at $249.96 on Wednesday.

    Check This Out:

    • Top 3 Industrials Stocks That Could Sink Your Portfolio This Month
    Get the next $AXP alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AXP
    $EBS

    CompanyDatePrice TargetRatingAnalyst
    American Express Company
    $AXP
    12/8/2025Peer Perform
    Wolfe Research
    American Express Company
    $AXP
    10/21/2025$340.00Sell → Hold
    DZ Bank
    American Express Company
    $AXP
    7/21/2025Hold → Sell
    DZ Bank
    American Express Company
    $AXP
    7/15/2025Buy → Neutral
    Monness Crespi & Hardt
    American Express Company
    $AXP
    4/23/2025$255.00Sell → Neutral
    Redburn Atlantic
    American Express Company
    $AXP
    4/21/2025$275.00 → $285.00Buy
    Monness Crespi & Hardt
    American Express Company
    $AXP
    4/11/2025$274.00Neutral → Buy
    BofA Securities
    American Express Company
    $AXP
    3/14/2025$265.00Underperform → Neutral
    Robert W. Baird
    More analyst ratings

    $AXP
    $EBS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program

    WINNIPEG, Manitoba, April 09, 2026 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE:EBS) announced that it has partnered with the B.C. Provincial Health Services Authority (PHSA) to supply NARCAN® Nasal Spray for the province's Take-Home Naloxone Program (BC THN Program). This order follows an additional investment of $18 million CAD by the B.C. government to expand the BC THN Program to include nasal naloxone. This is an expansion of B.C.'s nasal naloxone pilot program, which launched in 2024, and provided 60,000 nasal naloxone kits to community sites, pharmacies, post-secondary institutions, First-Nations-mandated institutions, fire departments, municipalities and libraries. "We ap

    4/9/26 4:25:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

    GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced a series of initiatives designed to help increase access to NARCAN® Nasal Spray and encourage the public to be ready to respond to an opioid overdose. These include the launch of the new NARCAN® Nasal Spray Carrying Case, the expanded availability of NARCAN® Nasal Spray multipacks and a college campus engagement featuring Pro Football Hall of Famer, Emmitt Smith and Release Recovery Founder/CEO, Zac Clark at Southern Methodist University (SMU). The new NARCAN® Nasal Spray Carrying Case is designed to be easy to carry, compact, discreet and durable, helping to ensure it's on hand whe

    4/7/26 8:05:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    American Express, Resy and Chef's Table Announce Expansive Partnership to Transform Culinary Storytelling Into Real-World Dining Experiences

    The collaboration kicks off this June with an intimate narrative-driven dinner series, followed by a culinary festival and an awards ceremony American Express, Resy and Chef's Table are embarking on a multi-year partnership that will extend the groundbreaking Netflix series into immersive programming for chef-obsessed diners and American Express® Card Members. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260402962422/en/American Express, Resy, and Chef's Table kick off their expansive partnership this June with an intimate narrative-driven dinner series, followed by a culinary festival and an awards ceremony. The partnership

    4/2/26 9:00:00 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Wolfe Research resumed coverage on American Express

    Wolfe Research resumed coverage of American Express with a rating of Peer Perform

    12/8/25 8:44:14 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    American Express upgraded by DZ Bank with a new price target

    DZ Bank upgraded American Express from Sell to Hold and set a new price target of $340.00

    10/21/25 7:12:42 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    American Express downgraded by DZ Bank

    DZ Bank downgraded American Express from Hold to Sell

    7/21/25 8:26:18 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wallace Noel R.

    4 - AMERICAN EXPRESS CO (0000004962) (Issuer)

    4/6/26 4:06:52 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Williams Paul Anthony

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    4/3/26 4:05:55 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Young Christopher David

    4 - AMERICAN EXPRESS CO (0000004962) (Issuer)

    4/2/26 4:14:53 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    SEC Filings

    View All

    SEC Form SCHEDULE 13G filed by Emergent BioSolutions Inc.

    SCHEDULE 13G - Emergent BioSolutions Inc. (0001367644) (Subject)

    4/9/26 1:42:19 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Emergent BioSolutions Inc.

    SCHEDULE 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    3/26/26 6:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form DEFA14A filed by American Express Company

    DEFA14A - AMERICAN EXPRESS CO (0000004962) (Filer)

    3/25/26 8:11:25 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Grp. Pres., Global Comm. Serv. Joabar Raymond bought $4,054 worth of shares (23 units at $176.26) and sold $12,257 worth of shares (40 units at $306.42) (SEC Form 4)

    4 - AMERICAN EXPRESS CO (0000004962) (Issuer)

    3/13/26 4:40:36 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    President and CEO Papa Joseph C bought $349,800 worth of shares (60,000 units at $5.83), increasing direct ownership by 21% to 342,500 units (SEC Form 4)

    4 - Emergent BioSolutions Inc. (0001367644) (Issuer)

    5/15/25 4:02:40 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Angelakis Michael J bought $998,593 worth of shares (3,700 units at $269.89) (SEC Form 4)

    4 - AMERICAN EXPRESS CO (0000004962) (Issuer)

    3/11/25 8:40:00 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    Leadership Updates

    Live Leadership Updates

    View All

    American Express Expands Global Sports and Entertainment Footprint with New Stadium and NFL Team Partnerships

    New partnerships with MetLife Stadium, New York Giants, New York Jets, Mercedes-Benz Stadium and Atlanta Falcons will deliver exclusive access, value and experiences for American Express® Card Members American Express (NYSE:AXP) will soon offer exclusive access, value and experiences for Card Members in the New York/New Jersey and Atlanta metropolitan areas through new long-term partnerships. American Express will be named the Official Payments Partner of MetLife Stadium, the New York Jets, the New York Giants, Mercedes-Benz Stadium, the Atlanta Falcons, Atlanta United and the newly awarded National Women's Soccer League (NWSL) team which will begin play in 2028. This builds on partnershi

    3/4/26 11:00:00 AM ET
    $AXP
    Finance: Consumer Services
    Finance

    Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

    GAITHERSBURG, Md., March 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced the appointment of John D. Fowler, Jr. to its board of directors effective March 1, 2026. Mr. Fowler brings more than three decades of leadership experience across the healthcare and financial services sectors. He will serve on the Audit and Finance Committee. "We're pleased to welcome John to the board of directors at this important point in the company's ongoing turnaround and transformation," said Dr. Zsolt Harsanyi, Ph.D., chairman of the board. "John's deep experience in healthcare and financial markets will provide valuable insight as the company continues to execute against i

    3/3/26 8:00:00 AM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Agentic AI Foundation Welcomes 97 New Members As Demand for Open, Collaborative Agent Standardization Increases

    Industry leading organizations unite under neutral Foundation led by new governing board chair David Nalley to support the future of interoperable AISummaryAgentic AI Foundation (AAIF) appoints David Nalley as governing board chair, and welcomes 18 new Gold Members and 79 new Silver Members.Under the AAIF, members help to reduce fragmentation in the ecosystem, improve interoperability, shape standards and advance open protocols.New Gold Members include industry leaders Akamai, American Express, Autodesk, Circle, Diagrid, Equinix, Global Payments, Hitachi, Huawei, Infobip, JPMorgan Chase, Keycard, Lenovo, Red Hat, ServiceNow, TELUS, UiPath and Workato.NAPA, Calif., Feb. 24, 2026 /PRNewswire/

    2/24/26 12:00:00 PM ET
    $ADSK
    $AXP
    $CRCL
    Computer Software: Prepackaged Software
    Technology
    Finance: Consumer Services
    Finance

    $AXP
    $EBS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Emergent BioSolutions Inc.

    SC 13G - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/13/24 4:00:18 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Emergent BioSolutions Inc.

    SC 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    11/8/24 5:23:28 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Emergent BioSolutions Inc.

    SC 13G/A - Emergent BioSolutions Inc. (0001367644) (Subject)

    9/10/24 12:09:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AXP
    $EBS
    Financials

    Live finance-specific insights

    View All

    American Express Updates First-Quarter 2026 Earnings Date and Plans to Host Live Audio Webcast of Annual Meeting of Shareholders

    American Express Company (NYSE:AXP) today has announced that it has adjusted the date of its first-quarter 2026 earnings release and conference call to Thursday, April 23, 2026, from Friday, April 24, 2026, previously. The company plans to host a live audio webcast of its earnings conference call to discuss its first-quarter 2026 financial results at 8:30 a.m. (ET) on Thursday, April 23, 2026. The live audio webcast will be accessible to the general public through the American Express Investor Relations website at https://ir.americanexpress.com/, and a webcast replay will be available on the website following the call. The financial results and presentation materials are scheduled to be r

    3/4/26 4:15:00 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    American Express Board Authorizes 16 Percent Increase in Common Shares Dividend

    The Board of Directors of American Express Company (NYSE:AXP) has approved a $0.13, or 16 percent, increase in the quarterly dividend on the company's common shares, consistent with the planned increase discussed in the company's fourth-quarter 2025 earnings release. The dividend was raised to $0.95 per common share, from $0.82, payable on May 8, 2026, to shareholders of record on April 3, 2026. ABOUT AMERICAN EXPRESS American Express (NYSE:AXP) is a global payments and premium lifestyle brand powered by technology. Our colleagues around the world back our customers with differentiated products, services, and experiences that enrich lives and build business success. Founded in 1850 an

    3/2/26 4:15:00 PM ET
    $AXP
    Finance: Consumer Services
    Finance

    Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results

    Fourth Quarter 2025 Total Revenues of $148.7 million; Full Year 2025 Total Revenues of $742.9 millionFourth Quarter 2025 Net Loss of $54.6 million and Net Loss Margin of 37%Full Year 2025 Net Income of $52.6 million versus a Net Loss of $190.6 million in the prior yearFull Year 2025 Net Income per diluted share of $0.93 versus a Net Loss per diluted share of $3.60 in the prior yearFull Year 2025 Adjusted Net Income of $86.8 million versus an Adjusted Net Loss of $12.1 million in the prior yearFull Year 2025 Adjusted Net Income per diluted share of $1.53 versus an Adjusted Net Loss per diluted share of $0.23 in the prior yearFull Year 2025 Gross Margin % of 45% and Adjusted Gross Margin % of

    2/26/26 4:05:00 PM ET
    $EBS
    Biotechnology: Pharmaceutical Preparations
    Health Care